TY - JOUR
T1 - Structure-based deformable image registration: Added value for dose accumulation of external beam radiotherapy and brachytherapy in cervical cancer
AU - van Heerden, Laura E.
AU - Houweling, Antonetta C.
AU - Koedooder, Kees
AU - van Kesteren, Zdenko
AU - van Wieringen, Niek
AU - Rasch, Coenraad R. N.
AU - Pieters, Bradley R.
AU - Bel, Arjan
PY - 2017
Y1 - 2017
N2 - Background and purpose Structure-based deformable image registration (DIR) can be used to calculate accumulated brachytherapy (BT) and external-beam radiation therapy (EBRT) dose–volume histogram (DVH) parameters in cervical cancer. Since direct parameter addition does not take dose non-uniformity into account, the added value of DIR over addition methods was investigated for bladder and rectum. Materials and methods For twelve patients (EBRT: 46 Gy, EBRT + BT: D90 85–90 GyEQD2 in equivalent dose in 2 Gy fractions) the EBRT planning CT and BT planning MRI were registered using DIR. Affected lymph nodes, located far from the BT boost region, received an EBRT boost (9.2 Gy) not contributing to the BT boost dose. Cumulative bladder/rectum D2cm3/D1cm3 were calculated and compared to direct addition methods, assuming uniform EBRT doses (UD), or overlapping high dose volumes (OHD). Results Between the three methods, the maximum differences in the cumulative DVH parameters were 3.2 GyEQD2 (bladder) and 3.3 GyEQD2 (rectum). The difference between DIR and UD was <1.8 GyEQD2 for both organs. Conclusions The UD method provides a better estimate of D2cm3/D1cm3 than the OHD method. There is no added value of DIR since differences with direct addition methods are clinically insignificant. EBRT dose distributions can be considered uniform in bladder and rectum for the evaluated dose parameters.
AB - Background and purpose Structure-based deformable image registration (DIR) can be used to calculate accumulated brachytherapy (BT) and external-beam radiation therapy (EBRT) dose–volume histogram (DVH) parameters in cervical cancer. Since direct parameter addition does not take dose non-uniformity into account, the added value of DIR over addition methods was investigated for bladder and rectum. Materials and methods For twelve patients (EBRT: 46 Gy, EBRT + BT: D90 85–90 GyEQD2 in equivalent dose in 2 Gy fractions) the EBRT planning CT and BT planning MRI were registered using DIR. Affected lymph nodes, located far from the BT boost region, received an EBRT boost (9.2 Gy) not contributing to the BT boost dose. Cumulative bladder/rectum D2cm3/D1cm3 were calculated and compared to direct addition methods, assuming uniform EBRT doses (UD), or overlapping high dose volumes (OHD). Results Between the three methods, the maximum differences in the cumulative DVH parameters were 3.2 GyEQD2 (bladder) and 3.3 GyEQD2 (rectum). The difference between DIR and UD was <1.8 GyEQD2 for both organs. Conclusions The UD method provides a better estimate of D2cm3/D1cm3 than the OHD method. There is no added value of DIR since differences with direct addition methods are clinically insignificant. EBRT dose distributions can be considered uniform in bladder and rectum for the evaluated dose parameters.
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85016406900&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/28372889
U2 - 10.1016/j.radonc.2017.03.015
DO - 10.1016/j.radonc.2017.03.015
M3 - Article
C2 - 28372889
SN - 0167-8140
VL - 123
SP - 319
EP - 324
JO - Radiotherapy and Oncology
JF - Radiotherapy and Oncology
IS - 2
ER -